648905-79-7Relevant articles and documents
A selective estrogen receptor modulator for the treatment of hot flushes
Wallace, Owen B.,Lauwers, Kenneth S.,Dodge, Jeffrey A.,May, Scott A.,Calvin, Joel R.,Hinklin, Ronald,Bryant, Henry U.,Shetler, Pamela K.,Adrian, Mary D.,Geiser, Andrew G.,Sato, Masahiko,Burris, Thomas P.
, p. 843 - 846 (2007/10/03)
A selective estrogen receptor modulator (SERM) for the potential treatment of hot flushes is described. (R)-(+)-7,9-difluoro-5-[4-(2-piperidin-1-ylethoxy) phenyl]-5H-6-oxachrysen-2-ol, LSN2120310, potently binds ERα and ERβ and is an antagonist in MCF-7 b
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats
Hummel, Conrad W.,Geiser, Andrew G.,Bryant, Henry U.,Cohen, Ilene R.,Dally, Robert D.,Fong, Kin Chiu,Frank, Scott A.,Hinklin, Ronald,Jones, Scott A.,Lewis, George,McCann, Denis J.,Rudmann, Daniel G.,Shepherd, Timothy A.,Tian, Hongqi,Wallace, Owen B.,Wang, Minmin,Wang, Yong,Dodge, Jeffrey A.
, p. 6772 - 6775 (2007/10/03)
The design of a novel selective estrogen receptor modulator (SERM) for the potential treatment of uterine leiomyoma is described. 16 (LY2066948-HCl) binds with high affinity to estrogen receptors α and β (ERα and ERβ, respectively) and is a potent uterine
SELECTIVE ESTROGEN RECEPTOR MODULATORS
-
Page/Page column 11-12, (2010/02/13)
The present invention relates to a selective estrogen receptor modulator of formula I: I; or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma. X16065 PCT - -